About Ansh Labs
Ansh Labs is a company based in Webster (United States) founded in 2010 was acquired by VION Biosciences in August 2024. The company has 33 employees as of December 31, 2022. Ansh Labs offers products and services including Immunoassays, Antibodies, and Antigens. Ansh Labs operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, PrognomiQ and Stem Cell Technologies, among others.
- Headquarter Webster, United States
- Employees 33 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
33
as on Dec 31, 2022
-
Acquired by
VION Biosciences
(Aug 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ansh Labs
Ansh Labs offers a comprehensive portfolio of products and services, including Immunoassays, Antibodies, and Antigens.
Assays for detecting biomarkers in research and clinical settings.
Developed for optimal binding in immunoassays.
Components used in immunoassays for biomarker analysis.
People of Ansh Labs
Unlock access to complete
Software Development Team
2 people
Scientist Team
1 people
Scientific Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Ansh Labs
Detailed funding history for Ansh Labs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ansh Labs
Ansh Labs has secured backing from 1 investor. Prominent investors backing the company include VION Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides end-to-end solutions for drug development, diagnostics, and research manufacturing.
|
Locked | Locked | Locked |
Investor details for Ansh Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ansh Labs
Investment portfolio details for Ansh Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ansh Labs
Detailed financials for Ansh Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ansh Labs Comparisons
Peer comparison for Ansh Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ansh Labs
Ansh Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, PrognomiQ and Stem Cell Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
Detailed competitors of Ansh Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ansh Labs
Complete news archive for Ansh Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ansh Labs
Ansh Labs was founded in 2010.
Ansh Labs is headquartered in Webster, United States. It is registered at Webster, New York, United States.
As of Dec 31, 2022, the latest employee count at Ansh Labs is 33.
Ansh Labs was founded in 2010 in Webster, United States, within the biotechnology sector. Immunoassay reagents and kits are produced for life science research, drawing from biomarker studies. Clinical applications are targeted in reproductive medicine, neurodegenerative disorders, and oncology. Support is provided to researchers in translational medicine and clinical diagnostics through these tools.
Ansh Labs's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Ansh Labs offers Immunoassays, Antibodies, and Antigens.
Ansh Labs has 1 investor. Key investors include VION Biosciences.